GAMMA Investing’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3K Buy
1,035
+174
+20% +$2.14K ﹤0.01% 3324
2026
Q2
$11.3K Buy
861
+124
+17% +$1.54K ﹤0.01% 3142
2026
Q1
$8.34K Buy
737
+635
+623% +$6.99K ﹤0.01% 3165
2025
Q4
$817 Buy
102
+13
+15% +$304 ﹤0.01% 3841
2025
Q3
$4.26K Buy
89
+23
+35% +$510 ﹤0.01% 3237
2025
Q2
$824 Sell
66
-527
-89% -$7.59K ﹤0.01% 3573
2025
Q1
$10.3K Buy
593
+585
+7,313% +$17.3K ﹤0.01% 2729
2024
Q4
$305 Buy
8
+4
+100% +$206 ﹤0.01% 3658
2024
Q3
$134 Buy
+4
New +$168 ﹤0.01% 3548

Other funds holding KRRO

GAMMA Investing's KRRO Position: Q3 2026 in Review

GAMMA Investing increased its Korro Bio (KRRO) stake by 20% in Q3 2026, buying an estimated $2.14K and bringing the position to 1,035 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3324.

GAMMA Investing first reported a position in KRRO in Q3 2024 and has held it in 9 quarters since. The position peaked at $11.3K in Q2 2026. 13 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

  • GAMMA Investing held 1,035 shares of Korro Bio worth $10.3K as of Q3 2026.
  • GAMMA Investing bought 174 Korro Bio shares in Q3 2026, an estimated $2.14K.
  • Korro Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3324 holding.
  • GAMMA Investing first reported a position in Korro Bio in Q3 2024 and has held it in 9 quarters since.
  • GAMMA Investing's Korro Bio position peaked at $11.3K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.